Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Growth arrest-specific protein 7 (GAS7) is primarily expressed in terminally differentiated brain cells, especially mature cerebellar Purkinje neurons, where it may promote neuronal maturation and differentiation. GAS7 contains domains similar to those in synapsins and certain transcription factors, suggesting roles in cytoskeletal regulation and possibly gene expression. It has been implicated in morphological neuronal development, with reduced expression interfering with neurite formation and overexpression promoting neurite-like outgrowth. GAS7 is not generally considered a direct therapeutic target such as a receptor, enzyme, or transporter, but it is associated with some diseases, including specific neurodegenerative conditions and glaucoma[1][2][3][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Growth arrest-specific protein 7 (GAS7).